Rating Change
B of A Securities analysts initiated coverage on ProQR Therapeutics N.V. (NASDAQ:PRQR) with a rating of Buy on August 20, 2026.
new coverageNASDAQ:PRQR
B of A Securities Initiates Coverage on ProQR Therapeutics N.V. (PRQR) with Buy
B of A Securities analysts initiated coverage on ProQR Therapeutics N.V. (NASDAQ:PRQR) with a rating of Buy on August 20, 2026.
At publication ·
What changed
ProQR Therapeutics N.V. (NASDAQ:PRQR) · new coverage
- Firm
- B of A Securities
- Rating
- Buy
- Price at event
- $2.37
- Market capitalization
- $249.7M
At a glance
Key takeaways
- B of A Securities initiated Buy coverage on ProQR Therapeutics (PRQR) on August 20, 2026, with the stock trading at $2.37 and a market capitalization of $249.7 million.
Market Context
ProQR Therapeutics N.V. operates in the Healthcare sector. The stock currently trades at $2.37 with a market capitalization of $249.7M.
Analyst coverage from B of A Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ProQR Therapeutics N.V.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ProQR Therapeutics N.V.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | B of A Securities | Buy | N/A |
| Jun 29, 2026 | Evercore ISI Group | Outperform | N/A |
| Jun 26, 2026 | Jones Trading | Buy | N/A |
| Jun 26, 2026 | Chardan Capital | Buy | N/A |
| Apr 09, 2026 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PRQR Stock Page
Frequently Asked Questions
What does the Buy rating mean for PRQR?
A rating of Buy from B of A Securities reflects the analyst's outlook on ProQR Therapeutics N.V. (NASDAQ:PRQR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PRQR forecast page.
